Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03857373

Renal Cancer Detection Using Convolutional Neural Networks

We aim to experiment and implement various deep learning architectures in order to achieve human-level accuracy in Computer-aided diagnosis (CAD) systems. In particular, we are interested in detecting renal tumors from CT urography scans in this project. We would like to classify renal tumor to cancer, non cancer, renal cyst I, renal cyst II, renal cyst III and renal cyst VI, with high sensitivity and low false positive rate using various types of convolutional neural networks (CNN). This task can be considered as the first step in building CAD systems for renal cancer diagnosis. Moreover, by automating this task, we can significantly reduce the time for the radiologists to create large-scale labeled datasets of CT-urography scans.

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Zealand University Hospital

Roskilde, 4000, Denmark

Location status: Recruiting

Location contact

Nessn Azawi, Ph.D

PRINCIPAL_INVESTIGATOR

Nessn H. Azawi, M.D.

CONTACT

[email protected]

004526393034

About this study

We aim to experiment and implement various deep learning architectures in order to achieve human-level accuracy in Computer-aided diagnosis (CAD) systems. In particular, we are interested in detecting renal tumors from CT urography scans in this project. We would like to classify renal tumor to cancer, non cancer, renal cyst I, renal cyst II, renal cyst III and renal cyst VI, with high sensitivity and low false positive rate using various types of convolutional neural networks (CNN). This task can be considered as the first step in building CAD systems for renal cancer diagnosis. Moreover, by automating this task, we can significantly reduce the time for the radiologists to create large-scale labeled datasets of CT-urography scans.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patient with RCC, who underwent surgery

Exclusion criteria

  • Patients with RCC, who did not underwent surgery

Treatment and study plan

Primary outcomes

  1. Predicting recurrences

    Time frame: 5 years

    Predicting recurrences of RCC

Study contacts

Contact information is provided by the study sponsor or research team.

Nessn Azawi, Phd

CONTACT

[email protected]

004526393034

Sponsors and collaborators

Lead sponsor

Nessn Azawi

Other

Registry information

Acronym: RCCCNN

Important dates

Study start
2019
Primary completion
2025
Study completion
2027
First posted
Feb 28, 2019
Registry last updated
Jan 30, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.